Unit Size: 2 mg per vial
Sequence: Tyr-D-Ala-Asp-Ala-ile-Phe-Thr- Gln-Ser-Tyr-Arg-Lys-Val-LeuAla-Gln-Leu-Ser-Ala-Arg-Lys- Leu-Leu-Gln-Asp-ile-Leu-Ser- Arg-Lys(Mal)-NH2
Molecular formula: C165H269N47046
Molecular Weight: 3647.15 g/mol CAS number: 863288-34-0
Market Status: Research use only
CJC-1295 DAC, also known as growth hormone releasing factor (GRF MOD (1-29) or GRF),
is an analogue of GHRH (growth hormone releasing hormone). CJC-1295 is a GHRH (the
44- amino acid long version) with 15 aminos removed, thus a total of 29 amino acids, and
bound to DAC it is also called Drug Affinity Complex, and CJC-1295 is often referred to as
GHRH with Drug Affinity Complex, this essentially lengthens its life span. CJC-1295 DAC
stimulates HGH and its interaction with GHRH in the body produces a family of growth
hormones. No other peptides will not produce such a wide spectrum of growth hormones
such as CJC-1295. Unique characteristics of CJC- 1295 is a fact that can influence an
increase in the amount of secretory cells and pituitary growth hormone, which can produce.
The difference between CJC- 1295 and CJC-1295 DAC is that CJC-1295 DAC version CJC1295 with the addition of so- called. Drug Affinity Complex (DAC), which significantly prolong
their effects and action. This means that the product will act in the body much longer than is
usual in CJC-1295 (without DAC), namely up to 14 days. At the same time CJC-1295 DAC
does not have such a steep ramp (sharp increase HGH levels) as CJC-1295, but it causes a
smoother and more even increased levels of HGH. Clinical tests found that after one
injection of CJC-1295 DAC content is increased growth hormone in the blood plasma from 3
to 10 times for 6 days, and increased IGF-1 concentrations 1.5-3 times for 9-12 days. The
main effects of CJC-1295 DAC: I enhances secretion of growth hormone in the blood I helps
achieve significant muscle hardness I promotes muscle growth and strength I helps burn fat
effectively – visibly improves skin quality, has a rejuvenating effect and smooths wrinkles I
increases bone density – effectively strengthens ligaments and joints – has a significant
positive effect on sleep, regeneration and vitality
In a CJC-1295 pulsatility study performed on normal non-GH deficient people reported
plasma levels were between 1 and 2 ng/ml or 1000-2000ng/L one week after injection of
between 60 or 90 mcg/kg of CJC-1295. In a 100kg man that is a 6mg or 9mg per week dose.
The optimal dose of CJC-1295 DAC is 1000-4000 mcg per week (3-4 evenly spaced doses).
CJC-1295 DAC is not suitable to separate solo use, and is often combined together with
GHRP-6, GHRP-2 or Hexarelin Ipamorelin to achieve a synergistic effect which significantly
increases the amount of growth hormone (HGH). dnestota Based on the patient monitoring
the most popular combinations of CJC-1295 DAC is with GHRP-2, GHRP-6, and ginseng,
which is one of the most to gain muscle mass.
Strong head rush can be-E observed in some patients about 20 minutes after the injection.
Store under 2…8°C. Do not freeze. Protect from direct sunlight.
Manufactured by: Hilma Biocare
Distributed by: 4 Rein Farmacie, Belgium